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Physician-Preferred Versus Policy-Based Testing
Where Do Appropriate Use Criteria Fit In?*
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A“It is much more important to know what sort of a
patient has a disease than what sort of a disease a
patient has.”
—Sir William Osler (1)
Coronary artery disease (CAD) is the leading cause
of morbidity and mortality in the United States,
accounting for 800,000 myocardial infarctions and
1 of every 5 deaths in 2009 (2). The overall annual
costs of CAD to the U.S. healthcare system are
enormous, and estimated to be upward of $500
billion annually. These findings highlight the need
for better evaluation of persons at risk for CAD
events. Currently, a multitude of noninvasive im-
aging modalities are available for evaluation of
patients with suspected CAD, and include stress
See page 297
echocardiography (SE), myocardial perfusion
single-photon emission computed tomography
(CT), positron emission tomography, coronary CT
angiography, and cardiac magnetic resonance im-
aging. These tests are employed for an array of
reasons, including, but not limited to, their high
diagnostic performance, enhanced risk predic-
tion, and lengthy “warranty period” after a nor-
mal test (3).
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interest in TC3 and MDDX.Yet the penchant for use of these testing modal-
ties has resulted in an unbridled consumption of
AD imaging resources. Diagnostic imaging has
ncreased more rapidly than any other aspect of
are, with use of noninvasive stress imaging proce-
ures among Medicare beneficiaries proliferating at
n annual increase of 6.1% between 1993 and
001—a rate that was 3-fold higher than growth for
nvasive coronary angiography and revascularization
4). Across physician specialties, cardiologists rep-
esented the group with the greatest growth in
onsumption. Although this rate of growth has
essened over recent years, concerns about excess
tilization have remained.
Pursuant to this, the American College of Car-
iology (ACC) convened an Appropriate Use Cri-
eria (AUC) Task Force to classify commonly used
ardiac imaging tests—stratified by specific clinical
cenarios—as appropriate, inappropriate, or uncer-
ain (5). The concepts that underscore the AUC are
hat appropriateness should be an essential compo-
ent of the decision-making process as to whether
o perform testing. Although the ACC’s AUC are
idely published and readily available to cardiolo-
ists, their awareness and incorporation into daily
se is strictly optional, and as such, the impact of
UC on testing patterns remains unknown.
In this issue of iJACC, Willens et al. (6) exam-
ned at an academic medical center a single CAD
maging modality—namely, stress echocardiogra-
hy (SE)—for important issues related to AUC. In
articular, they: 1) examined temporal changes in
ppropriateness for ordered SEs when classified by
he 2008 SE ACC AUC to the more contemporary
011 SE ACC AUC; 2) performed a comparison of
CC AUC to the criteria of 2 radiology benefits
anagers (RBMs); and 3) determined the effective-
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311ness of an educational-based initiative for improv-
ing ACC AUC adherence.
Willens et al. (5) noted that 25% of ordered SEs
were considered in different ACC AUC categories
in 2008 versus 2011, with the percent of unclassi-
fiable clinical indications reduced from 10% to
1%. Myriad reasons may explain these findings,
including an evolution of AUC that iterates from its
application and feedback from its users, as well as
ensures its maximal applicability to daily clinical
practice. Given the relatively short time frame in
which the ACC AUC updates have occurred, a
contrary (and perhaps less attractive) explanation to
the reduced number of unclassifiable indications
may be that the scenarios embodied within the
AUC have been expanded at a rate that outpaces
the development of high-quality scientific evidence.
The most recent initiative of the ACC AUC Task
Force will address both of these potential explana-
tions by development of an AUC that encompasses
all testing modalities capable of CAD diagnosis in
an as rigorous and evidence-based fashion as pos-
sible. This multimodality AUC—expected for pub-
lication this year—will homogenize appropriate use
categories across different test types in an easy-to-
apply manner, andWillens’ data (6) suggest that the
scenarios addressed in the multimodality applica-
tion will encompass nearly all commonly used
clinical applications.
Further, Willens et al. (6) examined the resem-
blance of the SE ACC AUC to the criteria used by
2 large RBMs, noting that the correlation was
generally only fair (0.36 and 0.63). These findings
are also of high import, and underscore an increas-
ing quandry for practicing cardiologists. The RBMs
are employed by private payer plans and require
pre-authorization of CAD imaging tests such as SE
using a process by which a physician seeks “permis-
sion” to perform a test to ensure test coverage.
Based on algorithms that are variably based upon
ACC AUC, RBMs either approve or deny coverage
of an imaging study. If denied, an ordering physi-
cian may appeal to the medical director of an RBM,
who will either approve or re-deny pre-authorization.
Although the use of RBMs has been effective for
cost reduction to payer plans, these requirements
have drawn criticism from practitioners and physi-
cian specialty societies for a multitude of reasons.
Differences in pre-authorization requirements from
ACC AUC as well as across different RBMs are
often not publicly shared, and may differ even
within the same geographical region, thus promot-
ing a sense of frustration in practicing physicianswho contend that the lack of transparency engen-
ders confusion in daily practice (7). In this regard,
the ACC AUC may serve as a potentially useful
adjunct (or even substitute) to RBM policy by
empowering physicians to utilize imaging through
integration of the available scientific evidence and
expert consensus, and delivered through concise
guidance documents.
The potential effectiveness of the AUC has been
considered before, albeit in a therapeutic context
rather than a diagnostic one. Hemingway et al. (8)
examined 2,552 consecutive patients undergoing
invasive coronary angiography at 3 hospitals for
appropriateness of revascularization (either percuta-
neous coronary intervention [PCI] or coronary
artery bypass graft surgery) based on clinical indi-
cation, and followed up for 30 months (8). Among
one-third of 908 patients for whom PCI was judged
appropriate yet who did not undergo PCI, a 2-fold
higher rate of persistent angina was observed when
compared to patients who underwent PCI. Simi-
larly, among 1,353 patients for whom coronary
artery bypass graft surgery was considered appropri-
ate, the 26% who were treated without that surgery
were 4 times more likely to have myocardial infarc-
tion or to die, and 3 times more likely to have
angina.
In the Hemingway study (8), appropriateness
ratings were graded in an even more granular
fashion than summary measures of appropriate,
uncertain, or inappropriate—similar to the ACC
AUC—on a continuous scale from 1 to 9. Impor-
tantly, risk of adverse events was observed to in-
crease linearly in accordance with numerical rank-
ings, thus providing compelling data that the
category of “uncertain,” as was pointed out by
Willens et al. (6), represents a “gray zone” where
performance of a test such as SE may be clinically
indicated for specific patients. Yet in their study, SE
indications inclusive of the uncertain category
would have been denied 13% and 42% of the time
by RBMs. This finding is worthy of consideration,
given that it speaks to the issue of physician-
preferred, rather than policy-based, testing. When
confronted with a symptomatic patient with sus-
pected CAD, the practitioner relies on myriad
factors that determine his or her decision to proceed
with further testing. As encouraged by Sir William
Osler, “The good physician treats the disease; the
great physician treats the patient who has the
disease” (9). Algorithmic flow charts are useful for
general guidance, but can never be a substitute for
the art of medicine.
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312Yet Willens et al. (6) identified a potential
impediment to allowing practitioners unchecked
authorization for ordering imaging studies. Even
after oral, written, and electronic educational initia-
tives, the number of inappropriate SEs did not
decrease in their study, and represented approxi-
mately one-third of all SEs ordered. Indeed, while
the interobserver reproducibility for appropriateness
ratings was high, it was only moderate for choosing
the clinical indication for SE ordering. These find-
ings suggest that while physicians generally agree
(80%) on an appropriateness rating once a clinical
indication is defined, there remains a disconnect
between physicians about why they chose to order a
test for a specific patient in the first place (60%).
This is a critical finding, as it suggests that the most
potentially effective stage at which inappropriate
testing may be reduced is at the point of order
rather than at the point of service, a concept that
preliminary data suggest to be effective (10).
In sum, the study by Willens et al. (6) is an
important one, albeit with limitations. This study
was performed on a small sample at a single
academic medical center and is thus encumbered byin the utilization of diagnostic testing
and treatments for cardiovascular dis- 241–8.demic settings, where the majority of imaging is
performed. Further, this study only compared the
AUC to 2 RBMs whose criteria were available for
public consumption through the Internet, and it
may be possible that RBMs with unpublished
criteria for SE are in better agreement with ACC
AUC. Importantly, this study also lacked any eval-
uation of the downstream effects of ACC AUC
versus RBM criteria on clinical and/or economic
outcomes. Hence, any propitious effect of ACC
AUC adherence remains unknown. Overall, the
study by Willens et al. (6) illustrates several bene-
ficial aspects of ACC AUC using SE imaging as a
test case, and can serve as a springboard upon which
future large-scale studies can be based. By contin-
ued refinement, implementation, and education,
the intent of the ACC AUC may be realized,
namely, optimizing ordering patterns and judicious
performance of noninvasive cardiac imaging.
Reprint requests and correspondence: Dr. James K. Min,
edars-Sinai Medical Center, Cardiology, The Heart
nstitute, 8700 Beverly Boulevard, Taper Building, Room
253, Los Angeles, California 90048. E-mail: james.a lack of generalizability, particularly at nonaca- min@cshs.orgR E F E R E N C E S
1. Osler W. Aequanimitas. Philadel-
phia, PA: Blakiston, 1904.
2. Lloyd-Jones D, Adams R, Car-
nethon M, et al. Heart disease and
stroke statistics—2009 update: a re-
port from the American Heart As-
sociation Statistics Committee and
Stroke Statistics Subcommittee.
Circulation 2009;119:480–6.
3. Berman DS, Hachamovitch R, Shaw
LJ, et al. Roles of nuclear cardiology,
cardiac computed tomography, and
cardiac magnetic resonance: assess-
ment of patients with suspected cor-
onary artery disease. J Nucl Med
2006;47:74–82.
4. Lucas FL, DeLorenzo MA, Siewers
AE, Wennberg DE. Temporal trendsease in the United States, 1993-2001.
Circulation 2006;113:374–9.
5. Patel MR, Spertus JA, Brindis RG, et
al. ACCF proposed method for eval-
uating the appropriateness of cardio-
vascular imaging. J Am Coll Cardiol
2005;46:1606–13.
6. Willens HJ, Nelson K, Hendel RC.
Appropriate use criteria for stress
echocardiography: impact of updated
criteria on appropriateness ratings,
correlation with pre-authorization
guidelines, and effect of temporal
trends and an educational initiative on
utilization. J Am Coll Cardiol Img
2013;6:297–309.
7. Hendel RC. Utilization manage-
ment of cardiovascular imaging pre-
certification and appropriateness.
J Am Coll Cardiol Img 2008;1:8. Hemingway H, Crook AM, Feder G,
et al. Underuse of coronary revascular-
ization procedures in patients consid-
ered appropriate candidates for revas-
cularization. N Engl J Med 2001;344:
645–54.
9. Osler W. Available at: http://
thinkexist.com/quotation/the_good_
physician_treats_the_disease-the_great/
177894.html. Accessed January 29,
2013.
10. Khorasani R. Computerized physician
order entry and decision support: im-
proving the quality of care. Radio-
graphics 2001;21:1015–8.
Key Words: appropriate use
criteria y physician behavior y
stress echocardiography.
